Springer Nature and OpenEvidence announce agreement to maximise exposure of trusted findings on OpenEvidence platform. August 12, 2026 Springer Nature and OpenEvidence today announced a subscription agreement that brings peer-reviewed content from Springer Nature into OpenEvidence, where physicians can retrieve and cite it during patient care. This agreement takes effect August 5 and forms part of Springer Nature's community led ARC3 framework. Clinicians and healthcare professionals need quick and easy access to the very latest trusted insights to help inform their decisions. Today's announcement ensures they will have access to trusted scientific and medical content published by Springer Nature at the point of care, in the AI platform they already use. Frank Vranken Peeters, Chief Executive Officer at Springer Nature, said: "Springer Nature and OpenEvidence share a common goal - to achieve maximum exposure for scientific research, while ensuring authors receive clear attribution and that their work is connected back to its original source. By partnering with OpenEvidence, one of the leading services delivering clinical findings at the point of care for healthcare professionals, we can help clinicians access trusted research, therefore supporting better-informed decisions and greater real-world impact." Daniel Nadler, Chief Executive Officer of OpenEvidence, said: "Springer Nature publishes many of the world's most influential medical journals, books, and society publications. Bringing clinical findings from the Springer Nature portfolio into OpenEvidence widens the range of questions a physician can get a deeper sourced answer to, across every major area of medicine. And, in the process, connects the authors of practice-changing medicine and research with the clinicians who use it." This agreement, which forms part of Springer Nature's community-led ARC3 framework, means researchers will be able to benefit from greater use of their work and have confidence in how it is accessed. The ARC3 licensing framework ensures: * Clear attribution and links back to the original research; * Transparency around how research content is used; and * Alignment with Springer Nature's Responsible AI Principles

OneOncology and openevidence partner to improve cancer care nationwide. MIAMI & NASHVILLE, Tenn.-(BUSINESS WIRE)-#Oncology-OpenEvidence, the most widely used AI-powered medical search and clinical decision-support platform, and OneOncology, a physician-led national platform empowering independent medical specialty practices, today announced a partnership to embed OpenEvidence into certain clinical applications used across OneOncology's platform to enable physicians to use OpenEvidence for clinical evidence retrieval, reference and research. The integration is designed to make it easier for physicians at OneOncology partner practices to access OpenEvidence directly within their clinical workflows. Over time, the collaboration is expected to expand to include deeper integration with OneOncology's structured genomic data assets and clinical trials matching systems - further aligning evidence, precision oncology insights, and research opportunities at the point of care. In the United States, more than half of hematology/oncology physicians already use OpenEvidence to help inform their clinical decisions. Community physicians at OneOncology partner practices deliver modern, high-quality care to 1.5 million patients nationwide. More than 50 percent of cancer patients in the United States receive their care in community oncology practices. Community physicians manage hundreds of approved therapies across dozens of tumor types, navigate biomarker-driven treatment algorithms that shift with each new approval, and increasingly offer clinical trials that were once limited to academic centers. "Independent physicians across the OneOncology network treat a wide array of cancers across stages, bringing the latest research and treatment options to patients close to home," said Davey Daniel, MD, OneOncology's Chief Medical Officer. "As physicians who read constantly and stay engaged with emerging science, OpenEvidence will help our partners efficiently access the latest, best-available research and evidence, improving the physician experience and supporting better patient outcomes." "Integrating OpenEvidence directly into my workflow will make it easier to access the information I need at the point of care," said Emily Z. Touloukian, DO, FASCO, President and CEO of Coastal Cancer Center in Myrtle Beach, SC. "Oncology is where the information problem in medicine is most acute: the literature moves fast, treatment decisions are increasingly personalized, and the stakes are as high as they get," said Dr. Travis Zack, Chief Medical Officer of OpenEvidence. "OneOncology's partner practice physicians have built a network that brings clinical trials, leading treatment pathways and physician-led innovation into the community. Building OpenEvidence directly into that workflow means the latest evidence, OneOncology's treatment pathways and relevant trials all converge at the point of care." About OpenEvidence OpenEvidence is the fastest-growing and most widely-used clinical decision support platform and medical search engine among U.S. clinicians. According to independent studies, more American physicians use OpenEvidence than all other AI platforms combined. OpenEvidence is trusted by millions of verified healthcare professionals to make high-stakes clinical decisions at the point of care that are sourced, cited, and grounded in peer-reviewed medical literature. Founded with the mission to organize and expand the world's collective medical knowledge, OpenEvidence is actively used daily, on average, by the majority of physicians in the United States. OpenEvidence is free for all verified U.S. clinicians. Learn more at openevidence.com. About OneOncology OneOncology was founded by community physicians, for community physicians, with the mission of improving the lives of everyone living with cancer and other diseases. Its goal is to enable community medical practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. OneOncology supports its platform of community medical practices through group purchasing, operational optimization, practice growth, and clinical innovation. Its partner practices comprise approximately 2,300+ providers who care for approximately 1.5 million patients across 20 states. To learn more, visit oneoncology.com.

OpenEvidence launches new Education Platform offering continuing education (CE) and Maintenance of Certification (MOC) credit. MIAMI-(BUSINESS WIRE)-#CME-OpenEvidence, the leading AI-powered medical search and decision support platform, has launched a new education platform offering accredited, interprofessional continuing education (CE) and Maintenance of Certification (MOC) credits for NPI-verified physicians, nurse practitioners, and physician associates. Physicians can additionally earn Maintenance of Certification (MOC) credit through select certifying boards. As AI-powered clinical tools become increasingly common, it is essential that accredited CE keeps pace with the evolving reality of practice. The OpenEvidence Education Platform is powered by the same underlying models that support OpenEvidence, adapted to create personalized, accredited learning experiences for clinicians. Designed to bridge the gap between point-of-care practice and CE, the new accredited learning experience draws on each clinician's routine use of OpenEvidence. Clinicians often use OpenEvidence in the context of a patient case, clinical uncertainty, or a specific question arising in practice. The new learning experience builds on that engagement by inviting clinicians to reflect on what they learned from their interactions with searched-for material, and by linking those reflections to the content blueprints and requirements of participating certifying boards. The experience recognizes learning when clinicians engage with evidence-based content, consider its relevance to practice, identify a key learning point, and document reflection on how the information informs their clinical reasoning, knowledge, or future care decisions. This creates a more natural bridge between real-world information needs, accredited CE, and continuing certification. "The best learning in medicine comes from real patient care. We designed this experience around that principle, connecting clinical context, searched-for evidence, and reflective learning to the competencies defined by certifying boards," said Mondira Ray, MD, MBI, Senior Vice President of Clinical Informatics at OpenEvidence. "Our goal was to make earning CE and MOC credit feel like a natural and meaningful extension of clinical practice, not an added task." "What is particularly compelling is the depth of personalization," said Vishal Patel, MD, Vice President of Clinical Partnerships and AI Education at OpenEvidence. "Each activity is grounded in the educational framework of the clinician's specialty board, helping ensure that learning prompted by real clinical questions is connected to the knowledge and competencies most relevant to that clinician's practice." "We are excited to be collaborating on this robust platform as the accredited provider of the continuing education and certification learning experience associated with this cutting-edge tool, using AI effectively and responsibly," stated Dorothy Caputo, MA, BSN, RN, President of AKH, Inc., Advancing Knowledge in Healthcare. OpenEvidence is used by clinicians across every specialty and practice setting to bring high-quality, evidence-based decision support to the point of care. This new experience marks a shift toward a more individualized, streamlined, and practice-integrated model for accredited CE and continuing certification. It is available today at no cost to all NPI-verified physicians, nurse practitioners, and physician associates. Physicians completing their CME requirements can also track CME earned through OpenEvidence on the Accreditation Council for Continuing Medical Education's CME Passport(R) platform, where they can generate transcripts and monitor completion of state relicensing CME requirements. To learn more, visit openevidence.com/cme. About Accreditation: In support of improving patient care, this activity has been planned and implemented by AKH, Inc., Advancing Knowledge in Healthcare and OpenEvidence. AKH, Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. About OpenEvidence OpenEvidence is the most widely used medical AI platform among U.S. physicians and is trusted by hundreds of thousands of verified clinicians to support clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence was founded with the mission to organize and expand the world's collective medical knowledge. Learn more at openevidence.com.